New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
05:55 EDTWYN, WYN, TWX, TWX, MSG, MSG, RL, RL, MRO, MRO, ICE, ICE, CVS, CVS, CMI, CMI, CVH, CVH, GAS, GASCompanies reporting Before the Market Open on Wednesday, February 6
Notable companies reporting before the opening bell on Wednesday include AGL Resources (GAS), Coventry Health Care (CVH), Cummins (CMI), CVS Caremark (CVS), IntercontinentalExchange (ICE), Marathon Oil (MRO), Ralph Lauren (RL), Madison Square Garden (MSG), Time Warner (TWX), and Wyndham Worldwide (WYN).
News For GAS;CVH;CMI;CVS;ICE;MRO;RL;MSG;TWX;WYN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 14, 2015
10:47 EDTTWXTurner Broadcasting CEO says has seen ratings erosion at TNT, TBS
Subscribe for More Information
10:43 EDTTWXTurner Broadcasting CEO says 'bullish' time for Turner
Subscribe for More Information
07:41 EDTRLUSPA gets favorable ruling in trademark fight with Ralph Lauren, Reuters says
Subscribe for More Information
May 13, 2015
11:47 EDTCVSCVS Health says to pay $22M in settlement with DEA, USAO
CVS Health said in a regulatory filing that it has entered into an agreement with the U.S. Attorney’s Office for the Middle District of Florida and the U.S. Drug Enforcement Administration to resolve previously-disclosed allegations relating to the dispensing of certain controlled substances in Florida. CVS Health agreed to pay $22M and the settlement resolves all civil matters between the Company and the DEA in the state of Florida. This payment amount has been fully accrued for in prior fiscal periods.
09:21 EDTRLOn The Fly: Pre-market Movers
Subscribe for More Information
08:07 EDTRLRalph Lauren sees forex, global consumer spending remaining 'unpredictable'
Subscribe for More Information
08:07 EDTRLRalph Lauren seesn Q1 consolidated net revenues flat in constant currency
In the first quarter of Fiscal 2016, the Company expects consolidated net revenues to be flat in constant currency, as retail segment growth is offset by a decline in wholesale revenue which is impacted by our customers’ receipt plans due to an earlier Easter this year. Based on current exchange rates, foreign currency will have an approximate 600 basis point negative impact on revenue growth in the first quarter of Fiscal 2016. Operating margin for the first quarter of Fiscal 2016 is expected to be approximately 600-650 basis points below the comparable prior year period, primarily due to negative foreign currency effects, the quarterly revenue growth profile and timing of expense savings initiatives. The first quarter tax rate is estimated at 30%.
08:06 EDTRLRalph Lauren sees FY15 consolidated net revenue up mid single digits
The company currently expects consolidated net revenues for Fiscal 2016 to increase by mid-single digits in constant currency. The company says, "Based on current exchange rates, foreign currency will have an approximate 450 basis point negative impact on Fiscal 2016 revenue growth. Operating margin for Fiscal 2016 is currently expected to be 180-230 basis points below the prior year’s level due to negative foreign currency effects. The full year Fiscal 2016 tax rate is estimated at 30%. Capital expenditures are planned at approximately $400-$500 million in Fiscal 2016. This guidance excludes restructuring and other one-time related charges associated with our global brand reorganization. We expect these charges to be approximately $70-100 million over the course of Fiscal 2016."
08:06 EDTRLRalph Lauren board authorizes additional $500M stock repurchase program
Subscribe for More Information
08:05 EDTRLRalph Lauren reports Q4 EPS $1.69 ex-foreign currency impacts, consensus $1.32
Subscribe for More Information
07:16 EDTTWXMoffett Nathanson to hold a summit
Subscribe for More Information
06:55 EDTTWXInsiders speculate bidding war to erupt over AOL, Business Insider reports
The consensus speculation from investment bankers, hedge fund traders and people close to AOL (AOL) is that another company will emerge and offer a price for AOL that is higher than $50 per share, reports Business Insider. The potential suitors include Time Warner (TWX), Comcast (CMCSA), Yahoo (YHOO), Alibaba (BABA), Softbank (SFTBF), AT&T (T), Netflix (NFLX) and Apple (AAPL). Reference Link
May 12, 2015
15:00 EDTRLNotable companies reporting before tomorrow's open
Subscribe for More Information
14:11 EDTRLRalph Lauren technical comments before earnings
The shares have been in decline for the prior year, but ahead of earnings have entered a consolidation phase. That range is largely contained within the bounds of $130 to $140. Those two extremes of the range can help us understand where price may go following earnings. A breakout above $140 on better than expected news would turn the dominant downtrend to neutral. A rise above $149.16 would set the trend to bullish in the short-term, with next resistance at $153.27. That level is the bottom of the bearish gap down from February. A move further up into the gap would be bullish. If the news is bearish and the low of the range at $130 is taken out on the downside, it would signal a resumption of the downtrend. In that event next support would be at $127.29, which is the 52-week low. A breakdown below the 52-week low could see the following support levels become potential downside objectives depending on the degree of negative surprise: $122.98, $117.29, and $111.65.
May 11, 2015
08:41 EDTWYNWyndham launches new loyalty program, Wyndham Rewards
Subscribe for More Information
08:21 EDTMROMitsubishi UFJ to hold a tour
Energy Tour travels throughout Houston and San Antonio, Texas to meet with various energy companies on May 11.
08:04 EDTMROCredit Suisse to hold a symposium
Subscribe for More Information
07:40 EDTCVSFocus on Vertex will shift to pricing after Orkambi FDA meeting, WSJ says
An FDA advisory committee that meets Tuesday to decide whether to recommend approval of Vertex’s Orkambi will be closely watched by health insurers and pharmacy-benefit managers concerned that the experimental cystic-fibrosis drug will be high-priced, said The Wall Street Journal. Vertex hasn’t announced a price, but analyst at JPMorgan predict the drug will have a wholesale price of about $287,000 annually per patient. Publicly traded PBM owners include Catamaran (CTRX), which is being acquired by UnitedHealth (UNH), CVS Health (CVS) and Express Scripts (ESRX). Reference Link
May 10, 2015
18:05 EDTTWXFCC contract ruling may speed review of AT&T-DirecTV merger, WSJ says
Subscribe for More Information
17:35 EDTTWXDisney's 'Avengers: Age Of Ultron' leads U.S. weekend box office with $77.2M
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use